Combination of Temperature-Sensitive Stem Cells and Mild Hypothermia: A New Potential Therapy for Severe Traumatic Brain Injury
Authors:
- 20 September 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 29 (14) , 2393-2403
Abstract
Stem cell transplantation holds great potential for the treatment of traumatic brain injury (TBI). However, the micro-environment of reduced oxygen and accumulated toxins leads to low survival rates of grafted cells, which dramatically limits their clinical application. Mild hypothermia has been demonstrated to improve the micro-environment after severe TBI. Thus, we speculate that combinational therapy of mild hypothermia may promote survival of grafted cells, especially temperature-sensitive stem cells, which show the most activity in mild temperatures. In this study, we first isolated mesenchymal stem cells from umbilical cord (UCSMCs) and generated the temperature-sensitive UCSMCs (tsUCSMCs) by infection with a retrovirus carrying the temperature-sensitive tsA58 SV40 LT antigen gene. We demonstrated that tsUCSMCs grew and proliferated with more activity at 33°C than at 37°C by counting cell numbers with a hematocytometer, measuring the cell cycle with flow cytometry, and detecting proliferating cell nuclear antigen (PCNA) with immunofluorescence staining. Thereafter, we established the rat severe TBI model by fluid percussion, and injected PBS, UCSMCs, or tsUCSMCs into the injured region, and subject the animals to normothermia or mild hypothermia (33°C). We found that, compared with UCSMC or tsUCSMC treatment alone, their combination with hypothermia could significantly improve motor and cognitive function with more survival of the grafted cells. Furthermore, we observed that combined therapy with hypothermia and tsUCSMCs exerted the most protective effect on the recovery of neurological function of all the tested treatments, with the highest survival and proliferation rates, and the lowest apoptosis rate. Thus this may represent a new therapeutic strategy for the treatment of severe TBI.Keywords
This publication has 52 references indexed in Scilit:
- Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategiesTrends in Pharmacological Sciences, 2010
- When Hypothermia Meets Hypotension and Hyperglycemia: The Diverse Effects of Adenosine 5′-Monophosphate on Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Protection in Animal Models of Brain and Spinal Cord Injury with Mild to Moderate HypothermiaJournal of Neurotrauma, 2009
- Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injuryExperimental Neurology, 2009
- Moderate and severe traumatic brain injury in adultsThe Lancet Neurology, 2008
- Embryonic Stem Cell Transplantation after Experimental Traumatic Brain Injury Dramatically Improves Neurological Outcome, But May Cause TumorsJournal of Neurotrauma, 2007
- Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's DiseaseStem Cells, 2005
- Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical CordStem Cells, 2004
- Immortalized Dendritic Cell Line with Efficient Cross-Priming Ability Established from Transgenic Mice Harboring the Temperature-Sensitive SV40 Large T-Antigen GeneThe Journal of Biochemistry, 2004
- Conditional transformation of mouse pancreatic epithelial cells: an in vitro model for analysis of genetic events in pancreatocarcinogenesisBiochemical and Biophysical Research Communications, 2004